Maryland Measles Outbreak Raises Concerns Amid Vaccination Debate
Measles Outbreak Declared in Maryland Counties
The Maryland Department of Health has announced a measles outbreak in St. Mary’s, Carroll, and Cecil Counties. This follows the confirmation of 14 new cases among unvaccinated residents. The state now reports a total of 31 measles cases this year.
All cases since July 15 involve individuals who have not received the measles, mumps, and rubella (MMR) vaccine. Health officials identified most infections among household contacts, with no public exposure sites noted. The overall risk is considered low for those who are vaccinated.
Dr. Meena Seshamani, Maryland Department of Health Secretary, emphasized the need for increased vaccination rates, urging residents to “help keep our youngest safe and protect those who are most at risk.” Efforts include working with local health departments to improve immunization access.
Trump’s Stance on Vaccine Schedules
President Donald Trump continues to advocate for changes in childhood vaccination schedules, including splitting the combined MMR vaccine into separate injections. Trump’s comments suggest this overhaul could potentially prevent autism, a claim not supported by scientific research. Extensive studies indicate no causal link between the MMR vaccine and autism.
Centers for Medicare and Medicaid Services administrator Dr. Mehmet Oz reacted to Trump’s comments, asserting that the MMR vaccine is not dangerous. He emphasized the safety of the combined vaccine during an appearance on CBS News’ Face the Nation.
Trump’s executive order proposes separating the MMR components, despite ongoing measles epidemics across the country. Experts warn that separate shots could leave children unprotected longer, contradicting standard vaccination practices recommended by Maryland officials and other health authorities.
The Centers for Disease Control and Prevention and other organizations continue to endorse routine MMR vaccination for protection against measles. The standard schedule suggests the first dose at 12 to 15 months and a second dose at 4 to 6 years.